oncology
Which big pharma companies are going to be making the most from oncology in 2021?
Well-established drug development powerhouses Roche, Celgene, and Novartis are the biggest pharma firms by oncology revenue right now and are…
Japan’s Takeda is buying Ariad Pharma for $5.2bn — Is this deal a bellwether for the biotech industry in 2017?
Given the scarcity of commercially-ready oncology assets, cancer drugs are appealing to big pharma with lots of cash and high…
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox